Achillion Pharma (ACHN) Reports Q4 Loss of $0.12/Share
Tweet
Share
E-mail
Get Alerts ACHN Hot Sheet
Price: $0.79 --0%
Financial Fact:
Loss from operations: -21.55M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Loss from operations: -21.55M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
Achillion Pharma (NASDAQ: ACHN) reported Q4 EPS of ($0.12), versus ($0.17) reported last year. Revenue for the quarter came in at $12.2 million, versus $15.4 million reported last year.
For earnings history and earnings-related data on Achillion Pharma (ACHN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
- HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
